Refarmed Chemicals uncovers opportunities for API manufacturers
Refarmed Chemicals supplies over 100 competitively priced products to developers and producers of generic formulations
Country Business Reports interviews and articles by Discovery Reports www.discoveryreports.com
A US$158 billion industry, the global active pharmaceutical ingredients (API) market is expected to reach US$214 billion by 2021, and multiservice organisation Refarmed Chemicals is thrilled. The Swiss producer and marketer of innovative API helps suppliers and pharmaceutical manufacturers worldwide unlock opportunities in advancing generic and therapeutic formulations.
“We anticipate developments in the API market, so we have devoted time and effort to nurture long-term strategic cooperation with API producers and suppliers, particularly in Asia and China,” says Giuseppe Nonni, president. “Developing a generic formulation takes five to six years to reach marketing approval, so we are now targeting API for products that will be launched in 2023.”
Refarmed has been honing its API expertise for four decades, supplying more than 100 high-quality and competitively priced products to developers and producers of generic formulations. With large multinationals and medical groups dictating protocols and consolidating dominant positions through aggressive acquisition policies, Refarmed guides independent companies as they compete with the big groups by offering speed, flexibility, results orientation and accurate product choices.
In the global arena, Refarmed remains a safe port for all Chinese producers looking for a consistent marketing partner in the non-domestic space. The API expert acts as a bridge connecting customers and producers of formulations. It provides added value as it also offers a mix of competences – from marketing to strategic, logistics, technical and finance.
“In Asia, personal relationships, long-term friendship and mutual confidence are real assets,” Nonni says. “We are proud of our 30-year relationship with our partners in the region, and we continue to explore cooperations with excellent Chinese companies looking for hidden opportunities.”
Refarmed coordinates its multi-service activities in Asia through an office in India, two offices in China (Shanghai and Hangzhou) and two capital partnerships with API manufacturers in Zhejiang province.